rivastigmine has been researched along with Multiple Sclerosis in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bolognesi, ML; Cavalli, A; Melchiorre, C; Minarini, A; Recanatini, M; Rosini, M; Tumiatti, V | 1 |
| Bellman, S | 1 |
| Dong, S; Gao, X; He, D; Wang, D; Zhang, Y; Zhou, H | 1 |
| Ashtari, F; Janghorbani, M; Shaygannejad, V; Zakizade, N; Zanjani, HA | 1 |
| Hämäläinen, H; Hämäläinen, P; Huolman, S; Laine, T; Parkkola, R; Ruutiainen, J; Vorobyev, V | 1 |
| Guo, D; Hao, Z; He, D; Wu, B; Zhou, H | 1 |
| Baier, M; Hofmann, W; Mäurer, M; Meergans, M; Ortler, S; Scherer, P; Tracik, F | 1 |
| Matthews, PM; Palace, J; Parry, AM; Scott, RB; Smith, S | 1 |
| de Haan, RJ; Vermeulen, M | 1 |
5 review(s) available for rivastigmine and Multiple Sclerosis
| Article | Year |
|---|---|
Multi-target-directed ligands to combat neurodegenerative diseases.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Binding Sites; Calcium Channel Blockers; Chelating Agents; Cholinesterase Inhibitors; Humans; Huntington Disease; Ligands; Multiple Sclerosis; Neurodegenerative Diseases; Neurofibrillary Tangles; Neurotransmitter Agents; Parkinson Disease; Plaque, Amyloid | 2008 |
Pharmacological treatment for memory disorder in multiple sclerosis.
Topics: Adult; Donepezil; Ginkgo biloba; Humans; Indans; Memantine; Memory Disorders; Multiple Sclerosis; Neuroprotective Agents; Nootropic Agents; Phytotherapy; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine | 2017 |
Pharmacological treatment for memory disorder in multiple sclerosis.
Topics: Adult; Donepezil; Ginkgo biloba; Humans; Indans; Memantine; Memory Disorders; Middle Aged; Multiple Sclerosis; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Phytotherapy; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine | 2013 |
Pharmacologic treatment for memory disorder in multiple sclerosis.
Topics: Adult; Donepezil; Ginkgo biloba; Humans; Indans; Memantine; Memory Disorders; Middle Aged; Multiple Sclerosis; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Phytotherapy; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine | 2011 |
[New therapies in neurology, but who benefits?].
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Antiviral Agents; Carbamates; Humans; Interferon-beta; Migraine Disorders; Multiple Sclerosis; Nervous System Diseases; Netherlands; Neuroprotective Agents; Outcome Assessment, Health Care; Phenylcarbamates; Riluzole; Rivastigmine; Sumatriptan; Vasoconstrictor Agents | 1999 |
4 trial(s) available for rivastigmine and Multiple Sclerosis
| Article | Year |
|---|---|
Effects of rivastigmine on memory and cognition in multiple sclerosis.
Topics: Adolescent; Adult; Cholinesterase Inhibitors; Cognition Disorders; Double-Blind Method; Humans; Memory Disorders; Middle Aged; Multiple Sclerosis; Neuroprotective Agents; Phenylcarbamates; Placebos; Psychological Tests; Rivastigmine | 2008 |
The effects of rivastigmine on processing speed and brain activation in patients with multiple sclerosis and subjective cognitive fatigue.
Topics: Adult; Attention; Brain; Cholinesterase Inhibitors; Cognition; Cognition Disorders; Double-Blind Method; Female; Finland; Humans; Magnetic Resonance Imaging; Memory; Middle Aged; Multiple Sclerosis; Neuropsychological Tests; Phenylcarbamates; Placebos; Reaction Time; Rivastigmine; Time Factors; Treatment Outcome | 2011 |
Randomised multicentre trial on safety and efficacy of rivastigmine in cognitively impaired multiple sclerosis patients.
Topics: Adult; Cholinesterase Inhibitors; Cognition Disorders; Double-Blind Method; Female; Humans; Male; Mental Recall; Middle Aged; Multiple Sclerosis; Phenylcarbamates; Rivastigmine; Treatment Outcome | 2013 |
Potentially adaptive functional changes in cognitive processing for patients with multiple sclerosis and their acute modulation by rivastigmine.
Topics: Adult; Carbamates; Cholinesterase Inhibitors; Cognition; Double-Blind Method; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Neuronal Plasticity; Neuropsychological Tests; Phenylcarbamates; Prefrontal Cortex; Rivastigmine | 2003 |